tradingkey.logo

ReShape Lifesciences Inc

RSLS
View Detailed Chart

2.450USD

-0.040-1.61%
Market hours ETQuotes delayed by 15 min
13.04KMarket Cap
LossP/E TTM

ReShape Lifesciences Inc

2.450

-0.040-1.61%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.61%

5 Days

-1.21%

1 Month

+3.38%

6 Months

-97.24%

Year to Date

-97.80%

1 Year

-99.07%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(3)
Buy(2)
Indicators
Sell(1)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.087
Neutral
RSI(14)
43.335
Neutral
STOCH(KDJ)(9,3,3)
13.237
Oversold
ATR(14)
0.303
Low Volatility
CCI(14)
-75.289
Neutral
Williams %R
85.484
Oversold
TRIX(12,20)
-0.446
Sell
StochRSI(14)
92.387
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
2.438
Buy
MA10
2.668
Sell
MA20
2.647
Sell
MA50
3.132
Sell
MA100
7.188
Sell
MA200
56.900
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Ticker SymbolRSLS
CompanyReShape Lifesciences Inc
CEOMr. Paul F. Hickey
Websitehttps://www.reshapelifesciences.com/obalon/
KeyAI